{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T15:29:03Z","timestamp":1670945343604},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00059-021-05057-8","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T11:03:41Z","timestamp":1629803021000},"page":"429-436","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pushing the limits for interventional treatment of aortic valve stenosis"],"prefix":"10.1007","volume":"46","author":[{"given":"Erion","family":"Xhepa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector A.","family":"Alvarez-Covarrubias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"issue":"23","key":"5057_CR1","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith\u00a0CR, Leon\u00a0MB, Mack\u00a0MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N\u00a0Engl J Med 364(23):2187\u20132198. https:\/\/doi.org\/10.1056\/NEJMoa1103510","journal-title":"N Engl J Med"},{"issue":"19","key":"5057_CR2","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","volume":"370","author":"DH Adams","year":"2014","unstructured":"Adams\u00a0DH, Popma\u00a0JJ, Reardon\u00a0MJ et al (2014) Transcatheter aortic-valve replacement with a\u00a0self-expanding prosthesis. N\u00a0Engl J Med 370(19):1790\u20131798. https:\/\/doi.org\/10.1056\/NEJMoa1400590","journal-title":"N Engl J Med"},{"issue":"17","key":"5057_CR3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon\u00a0MB, Smith\u00a0CR, Mack\u00a0MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N\u00a0Engl J Med 374(17):1609\u20131620. https:\/\/doi.org\/10.1056\/NEJMoa1514616","journal-title":"N Engl J Med"},{"issue":"14","key":"5057_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","volume":"376","author":"MJ Reardon","year":"2017","unstructured":"Reardon\u00a0MJ, Van Mieghem\u00a0NM et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N\u00a0Engl J Med 376(14):1321\u20131331. https:\/\/doi.org\/10.1056\/NEJMoa1700456","journal-title":"N Engl J Med"},{"issue":"18","key":"5057_CR5","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack\u00a0MJ, Leon\u00a0MB, Thourani\u00a0VH et al (2019) Transcatheter aortic-valve replacement with a\u00a0balloon-expandable valve in low-risk patients. N\u00a0Engl J Med 380(18):1695\u20131705. https:\/\/doi.org\/10.1056\/NEJMoa1814052","journal-title":"N Engl J Med"},{"issue":"18","key":"5057_CR6","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma\u00a0JJ, Deeb\u00a0GM, Yakubov\u00a0SJ et al (2019) Transcatheter aortic-valve replacement with a\u00a0self-expanding valve in low-risk patients. N\u00a0Engl J Med 380(18):1706\u20131715. https:\/\/doi.org\/10.1056\/NEJMoa1816885","journal-title":"N Engl J Med"},{"issue":"9","key":"5057_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1910555","volume":"382","author":"RR Makkar","year":"2020","unstructured":"Makkar\u00a0RR, Thourani\u00a0VH, Mack\u00a0MJ et al (2020) Five-year outcomes of transcatheter or surgical aortic-valve replacement. N\u00a0Engl J Med 382(9):799\u2013809. https:\/\/doi.org\/10.1056\/NEJMoa1910555","journal-title":"N Engl J Med"},{"issue":"11","key":"5057_CR8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00392-019-01461-7","volume":"108","author":"C Pellegrini","year":"2019","unstructured":"Pellegrini\u00a0C, Rheude\u00a0T, Trenkwalder\u00a0T et al (2019) One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3. Clin Res Cardiol 108(11):1258\u20131265. https:\/\/doi.org\/10.1007\/s00392-019-01461-7","journal-title":"Clin Res Cardiol"},{"issue":"22","key":"5057_CR9","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/j.jcin.2020.07.013","volume":"13","author":"T Rheude","year":"2020","unstructured":"Rheude\u00a0T, Pellegrini\u00a0C, Lutz\u00a0J et al (2020) Transcatheter aortic valve replacement with balloon-expandable valves: comparison of SAPIEN 3 ultra versus SAPIEN 3. JACC Cardiovasc Interv 13(22):2631\u20132638. https:\/\/doi.org\/10.1016\/j.jcin.2020.07.013","journal-title":"JACC Cardiovasc Interv"},{"issue":"38","key":"5057_CR10","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1093\/eurheartj\/ehz275","volume":"40","author":"GCM Siontis","year":"2019","unstructured":"Siontis\u00a0GCM, Overtchouk\u00a0P, Cahill\u00a0TJ et al (2019) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart\u00a0J 40(38):3143\u20133153. https:\/\/doi.org\/10.1093\/eurheartj\/ehz275","journal-title":"Eur Heart J"},{"issue":"45","key":"5057_CR11","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/eurheartj\/ehx303","volume":"38","author":"D Capodanno","year":"2017","unstructured":"Capodanno\u00a0D, Petronio\u00a0AS, Prendergast\u00a0B et al (2017) Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a\u00a0consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart\u00a0J 38(45):3382\u20133390. https:\/\/doi.org\/10.1093\/eurheartj\/ehx303","journal-title":"Eur Heart J"},{"issue":"5","key":"5057_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jacc.2018.10.083","volume":"73","author":"L Sondergaard","year":"2019","unstructured":"Sondergaard\u00a0L, Ihlemann\u00a0N, Capodanno\u00a0D et\u00a0al (2019) Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J\u00a0Am Coll Cardiol 73(5):546\u2013553. https:\/\/doi.org\/10.1016\/j.jacc.2018.10.083","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"5057_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jamacardio.2017.3306","volume":"2","author":"PS Douglas","year":"2017","unstructured":"Douglas\u00a0PS, Leon\u00a0MB, Mack\u00a0MJ et\u00a0al (2017) Longitudinal hemodynamics of transcatheter and surgical aortic valves in the PARTNER trial. JAMA Cardiol 2(11):1197\u20131206. https:\/\/doi.org\/10.1001\/jamacardio.2017.3306","journal-title":"JAMA Cardiol"},{"issue":"16","key":"5057_CR14","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jacc.2020.08.049","volume":"76","author":"P Pibarot","year":"2020","unstructured":"Pibarot\u00a0P, Ternacle\u00a0J, Jaber\u00a0WA et al (2020) Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER\u20112 trial. J\u00a0Am Coll Cardiol 76(16):1830\u20131843. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.049","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"5057_CR15","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","volume":"42","author":"P Genereux","year":"2021","unstructured":"Genereux\u00a0P, Piazza\u00a0N, Alu\u00a0MC et\u00a0al (2021) Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart\u00a0J 42(19):1825\u20131857. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa799","journal-title":"Eur Heart J"},{"issue":"6","key":"5057_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jcin.2020.01.202","volume":"13","author":"T Rogers","year":"2020","unstructured":"Rogers\u00a0T, Greenspun\u00a0BC, Weissman\u00a0G et al (2020) Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients. JACC Cardiovasc Interv 13(6):726\u2013735. https:\/\/doi.org\/10.1016\/j.jcin.2020.01.202","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"5057_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jcin.2020.01.216","volume":"13","author":"T Ochiai","year":"2020","unstructured":"Ochiai\u00a0T, Chakravarty\u00a0T, Yoon\u00a0SH et\u00a0al (2020) Coronary access after TAVR. JACC Cardiovasc Interv 13(6):693\u2013705. https:\/\/doi.org\/10.1016\/j.jcin.2020.01.216","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"5057_CR18","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.jcin.2020.07.006","volume":"13","author":"M Barbanti","year":"2020","unstructured":"Barbanti\u00a0M, Costa\u00a0G, Picci\u00a0A et al (2020) Coronary cannulation after Transcatheter aortic valve replacement: the RE-ACCESS study. JACC Cardiovasc Interv 13(21):2542\u20132555. https:\/\/doi.org\/10.1016\/j.jcin.2020.07.006","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"5057_CR19","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.jacc.2021.03.014","volume":"77","author":"L Faroux","year":"2021","unstructured":"Faroux\u00a0L, Lhermusier\u00a0T, Vincent\u00a0F et al (2021) ST-segment elevation myocardial infarction following transcatheter aortic valve replacement. J\u00a0Am Coll Cardiol 77(17):2187\u20132199. https:\/\/doi.org\/10.1016\/j.jacc.2021.03.014","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5057_CR20","doi-asserted-by":"publisher","first-page":"e008044","DOI":"10.1161\/CIRCINTERVENTIONS.119.008044","volume":"12","author":"GHL Tang","year":"2019","unstructured":"Tang\u00a0GHL, Zaid\u00a0S, Gupta\u00a0E et\u00a0al (2019) Impact of initial evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess. Circ Cardiovasc Interv 12(7):e8044. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.008044","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"5057_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/heartjnl-2011-300065","volume":"98","author":"TA Fairbairn","year":"2012","unstructured":"Fairbairn\u00a0TA, Mather\u00a0AN, Bijsterveld\u00a0P et al (2012) Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 98(1):18\u201323. https:\/\/doi.org\/10.1136\/heartjnl-2011-300065","journal-title":"Heart"},{"issue":"13","key":"5057_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","volume":"348","author":"SE Vermeer","year":"2003","unstructured":"Vermeer\u00a0SE, Prins\u00a0ND, den Heijer\u00a0T et\u00a0al (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N\u00a0Engl J Med 348(13):1215\u20131222. https:\/\/doi.org\/10.1056\/NEJMoa022066","journal-title":"N Engl J Med"},{"issue":"1","key":"5057_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcin.2018.10.053","volume":"12","author":"TH Jorgensen","year":"2019","unstructured":"Jorgensen\u00a0TH, De Backer\u00a0O, Gerds\u00a0TA et\u00a0al (2019) Mortality and heart failure hospitalization in patients with conduction abnormalities after transcatheter aortic valve replacement. JACC Cardiovasc Interv 12(1):52\u201361. https:\/\/doi.org\/10.1016\/j.jcin.2018.10.053","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"5057_CR24","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1001\/jama.2014.3316","volume":"311","author":"M Abdel-Wahab","year":"2014","unstructured":"Abdel-Wahab\u00a0M, Mehilli\u00a0J, Frerker\u00a0C et al (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311(15):1503\u20131514. https:\/\/doi.org\/10.1001\/jama.2014.3316","journal-title":"JAMA"},{"issue":"2","key":"5057_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jcin.2020.10.033","volume":"14","author":"J Ben-Shoshan","year":"2021","unstructured":"Ben-Shoshan\u00a0J, Alosaimi\u00a0H, Lauzier\u00a0PT et al (2021) Double S\u2011curve versus cusp-overlap technique: defining the optimal fluoroscopic projection for TAVR with a\u00a0self-expanding device. JACC Cardiovasc Interv 14(2):185\u2013194. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.033","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"5057_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jama.2014.7246","volume":"312","author":"D Dvir","year":"2014","unstructured":"Dvir\u00a0D, Webb\u00a0JG, Bleiziffer\u00a0S et\u00a0al (2014) Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 312(2):162\u2013170. https:\/\/doi.org\/10.1001\/jama.2014.7246","journal-title":"JAMA"},{"issue":"8","key":"5057_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/eurheartj\/ehx455","volume":"39","author":"HB Ribeiro","year":"2018","unstructured":"Ribeiro\u00a0HB, Rodes-Cabau\u00a0J, Blanke\u00a0P et al (2018) Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart\u00a0J 39(8):687\u2013695. https:\/\/doi.org\/10.1093\/eurheartj\/ehx455","journal-title":"Eur Heart J"},{"issue":"6","key":"5057_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jcin.2020.01.227","volume":"13","author":"F Mercanti","year":"2020","unstructured":"Mercanti\u00a0F, Rosseel\u00a0L, Neylon\u00a0A et\u00a0al (2020) Chimney stenting for coronary occlusion during TAVR: insights from the chimney registry. JACC Cardiovasc Interv 13(6):751\u2013761. https:\/\/doi.org\/10.1016\/j.jcin.2020.01.227","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"5057_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jcin.2018.01.247","volume":"11","author":"JM Khan","year":"2018","unstructured":"Khan\u00a0JM, Dvir\u00a0D, Greenbaum\u00a0AB et al (2018) Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: concept to first-in-human. JACC Cardiovasc Interv 11(7):677\u2013689. https:\/\/doi.org\/10.1016\/j.jcin.2018.01.247","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"5057_CR30","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jcin.2019.03.035","volume":"12","author":"JM Khan","year":"2019","unstructured":"Khan\u00a0JM, Greenbaum\u00a0AB, Babaliaros\u00a0VC et\u00a0al (2019) The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv 12(13):1240\u20131252. https:\/\/doi.org\/10.1016\/j.jcin.2019.03.035","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"5057_CR31","doi-asserted-by":"publisher","first-page":"e010238","DOI":"10.1161\/CIRCINTERVENTIONS.120.010238","volume":"14","author":"JM Khan","year":"2021","unstructured":"Khan\u00a0JM, Greenbaum\u00a0AB, Babaliaros\u00a0VC et al (2021) BASILICA trial: one-year outcomes of transcatheter electrosurgical leaflet laceration to prevent TAVR coronary obstruction. Circ Cardiovasc Interv 14(5):e10238. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.010238","journal-title":"Circ Cardiovasc Interv"},{"issue":"22","key":"5057_CR32","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.jacc.2018.09.001","volume":"72","author":"HC Herrmann","year":"2018","unstructured":"Herrmann\u00a0HC, Daneshvar\u00a0SA, Fonarow\u00a0GC et al (2018) Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS\/ACC TVT registry. J\u00a0Am Coll Cardiol 72(22):2701\u20132711. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.001","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5057_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcin.2017.08.039","volume":"11","author":"P Pibarot","year":"2018","unstructured":"Pibarot\u00a0P, Simonato\u00a0M, Barbanti\u00a0M et al (2018) Impact of pre-existing prosthesis-patient mismatch on survival following aortic valve-in-valve procedures. JACC Cardiovasc Interv 11(2):133\u2013141. https:\/\/doi.org\/10.1016\/j.jcin.2017.08.039","journal-title":"JACC Cardiovasc Interv"},{"key":"5057_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005216","author":"AK Chhatriwalla","year":"2017","unstructured":"Chhatriwalla\u00a0AK, Allen\u00a0KB, Saxon\u00a0JT et al (2017) Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement. Circ Cardiovasc Interv. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005216","journal-title":"Circ Cardiovasc Interv"},{"issue":"26","key":"5057_CR35","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMsa1901109","volume":"380","author":"S Vemulapalli","year":"2019","unstructured":"Vemulapalli\u00a0S, Carroll\u00a0JD, Mack\u00a0MJ et al (2019) Procedural volume and outcomes for transcatheter aortic-valve replacement. N\u00a0Engl J Med 380(26):2541\u20132550. https:\/\/doi.org\/10.1056\/NEJMsa1901109","journal-title":"N Engl J Med"},{"key":"5057_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005456","author":"AC Fanaroff","year":"2017","unstructured":"Fanaroff\u00a0AC, Manandhar\u00a0P, Holmes\u00a0DR et\u00a0al (2017) Peripheral artery disease and transcatheter aortic valve replacement outcomes: a report from the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter therapy registry. Circ Cardiovasc Interv. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005456","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"5057_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.15420\/icr.2018.22.1","volume":"13","author":"P Overtchouk","year":"2018","unstructured":"Overtchouk\u00a0P, Modine\u00a0T (2018) Alternate access for TAVI: stay clear of the chest. Interv Cardiol 13(3):145\u2013150. https:\/\/doi.org\/10.15420\/icr.2018.22.1","journal-title":"Interv Cardiol"},{"issue":"22","key":"5057_CR38","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1016\/j.jacc.2019.09.054","volume":"74","author":"S Beurtheret","year":"2019","unstructured":"Beurtheret\u00a0S, Karam\u00a0N, Resseguier\u00a0N et\u00a0al (2019) Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement. J\u00a0Am Coll Cardiol 74(22):2728\u20132739. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.054","journal-title":"J Am Coll Cardiol"},{"issue":"25 Pt A","key":"5057_CR39","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.jacc.2014.04.015","volume":"63","author":"AB Greenbaum","year":"2014","unstructured":"Greenbaum\u00a0AB, O\u2019Neill\u00a0WW, Paone\u00a0G et al (2014) Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience. J\u00a0Am Coll Cardiol 63(25 Pt A):2795\u20132804. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.015","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5057_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jacc.2016.10.024","volume":"69","author":"AB Greenbaum","year":"2017","unstructured":"Greenbaum\u00a0AB, Babaliaros\u00a0VC, Chen\u00a0MY et\u00a0al (2017) Transcaval access and closure for transcatheter aortic valve replacement: a prospective investigation. J\u00a0Am Coll Cardiol 69(5):511\u2013521. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.024","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5057_CR41","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jcin.2018.11.035","volume":"12","author":"RJ Lederman","year":"2019","unstructured":"Lederman\u00a0RJ, Babaliaros\u00a0VC, Rogers\u00a0T et al (2019) The fate of transcaval access tracts: 12-month results of the prospective NHLBI transcaval transcatheter aortic valve replacement study. JACC Cardiovasc Interv 12(5):448\u2013456. https:\/\/doi.org\/10.1016\/j.jcin.2018.11.035","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"5057_CR42","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.jcin.2019.05.053","volume":"12","author":"T Rogers","year":"2019","unstructured":"Rogers\u00a0T, Greenbaum\u00a0AB, Babaliaros\u00a0VC et al (2019) Dedicated closure device for transcaval access closure: from concept to first-in-human testing. JACC Cardiovasc Interv 12(21):2198\u20132206. https:\/\/doi.org\/10.1016\/j.jcin.2019.05.053","journal-title":"JACC Cardiovasc Interv"},{"issue":"22","key":"5057_CR43","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1001\/jama.2019.7108","volume":"321","author":"RR Makkar","year":"2019","unstructured":"Makkar\u00a0RR, Yoon\u00a0SH, Leon\u00a0MB et\u00a0al (2019) Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic Stenosis and mortality or stroke. JAMA 321(22):2193\u20132202. https:\/\/doi.org\/10.1001\/jama.2019.7108","journal-title":"JAMA"},{"issue":"15","key":"5057_CR44","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.jcin.2020.03.022","volume":"13","author":"JK Forrest","year":"2020","unstructured":"Forrest\u00a0JK, Kaple\u00a0RK, Ramlawi\u00a0B et\u00a0al (2020) Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valves from the STS\/ACC TVT registry. JACC Cardiovasc Interv 13(15):1749\u20131759. https:\/\/doi.org\/10.1016\/j.jcin.2020.03.022","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"5057_CR45","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jacc.2020.07.005","volume":"76","author":"SH Yoon","year":"2020","unstructured":"Yoon\u00a0SH, Kim\u00a0WK, Dhoble\u00a0A et\u00a0al (2020) Bicuspid aortic valve morphology and outcomes after transcatheter aortic valve replacement. J\u00a0Am Coll Cardiol 76(9):1018\u20131030. https:\/\/doi.org\/10.1016\/j.jacc.2020.07.005","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5057_CR46","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.CIR.0000155623.48408.C5","volume":"111","author":"WC Roberts","year":"2005","unstructured":"Roberts\u00a0WC, Ko\u00a0JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111(7):920\u2013925. https:\/\/doi.org\/10.1161\/01.CIR.0000155623.48408.C5","journal-title":"Circulation"},{"issue":"6","key":"5057_CR47","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.athoracsur.2006.07.043","volume":"82","author":"RG Pai","year":"2006","unstructured":"Pai\u00a0RG, Kapoor\u00a0N, Bansal\u00a0RC, Varadarajan\u00a0P (2006) Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 82(6):2116\u20132122. https:\/\/doi.org\/10.1016\/j.athoracsur.2006.07.043","journal-title":"Ann Thorac Surg"},{"issue":"25","key":"5057_CR48","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1016\/j.jacc.2015.10.001","volume":"66","author":"T Taniguchi","year":"2015","unstructured":"Taniguchi\u00a0T, Morimoto\u00a0T, Shiomi\u00a0H et\u00a0al (2015) Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J\u00a0Am Coll Cardiol 66(25):2827\u20132838. https:\/\/doi.org\/10.1016\/j.jacc.2015.10.001","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"5057_CR49","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner\u00a0H, Falk\u00a0V, Bax\u00a0JJ et\u00a0al (2017) 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart\u00a0J 38(36):2739\u20132791. https:\/\/doi.org\/10.1093\/eurheartj\/ehx391","journal-title":"Eur Heart J"},{"issue":"2","key":"5057_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1912846","volume":"382","author":"DH Kang","year":"2020","unstructured":"Kang\u00a0DH, Park\u00a0SJ, Lee\u00a0SA et\u00a0al (2020) Early surgery or conservative care for asymptomatic aortic stenosis. N\u00a0Engl J Med 382(2):111\u2013119. https:\/\/doi.org\/10.1056\/NEJMoa1912846","journal-title":"N Engl J Med"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05057-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-021-05057-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05057-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:05:59Z","timestamp":1633007159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-021-05057-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["5057"],"URL":"https:\/\/doi.org\/10.1007\/s00059-021-05057-8","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"13 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.\u00a0Joner received lecture fees and research grants from Edwards Lifesciences and Boston Scientific and is a consultant for Biotronik and Orbus Neich. E.\u00a0Xhepa and H.A.\u00a0Alvarez-Covarrubias declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}